Work

Refractory lichen planus: success with dupilumab

Year: 2024

Type: article

Abstract: Lichen planus (LP) is an autoimmune inflammatory disease typically treated with topical and systemic corticosteroids, but biologics such as dupilumab are emerging as a novel therapeutic treatment. The literature suggests that dupilumab can improve LP symptoms, but there are limited reports of its efficacy. This case presents a 55-year-old African American man with refractory LP who failed multiple treatments but experienced improvement with dupilumab.

Source: Clinical and Experimental Dermatology

DOI: 10.1093/ced/llae425

Authors: Madison H Read, Elizabeth Swain, Katie K Lovell, Steven R Feldman

Institutions: Wake Forest University Health Sciences, Wake Forest University, University of Southern Denmark

Language: English

Topic: Oral Health Pathology and Treatment

Subfield: Periodontics

Field: Dentistry

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4403294131